Ma Isabel Medranda de LázaroMaría del Rosario Benítez Rubio
Analysis of real-world patient weight and BSA data allowed olaratumab vial size optimization to enable maximal dosing flexibility with minimal drug waste.
C Monserrat RipollJ Cardona PeretoF Llácer BorrásC Ortega AndrésF Tarín-RoyoC Ramos Bodi